Home › NDC Lookup › RxCUI directory › RxCUI 312025

Nizatidine 150 MG Oral Capsule — RxCUI 312025

RxNorm drug concept · Semantic clinical drug
RxCUI 312025 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312025
Official nameNizatidine 150 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped16
Reported Medicaid activity (SDUD)6,555 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nizatidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nizatidine is used to treat ulcers in the stomach and small intestine, and to manage acid reflux disease (GERD) — including when acid has caused actual damage or inflammation in th...
  • Your stomach has special cells that release acid when a chemical called histamine tells them to. Nizatidine blocks the histamine 'switch' on those cells — called H2 receptors — so...
  • You can take nizatidine with or without food — it doesn't make a big difference either way. One thing to avoid: if you're taking the capsule form, don't mix or dissolve it in apple...
  • Can I take nizatidine with food, or does it have to be on an empty stomach?
📖 Read our full Nizatidine guide →

🕸️ Concept Web — How Nizatidine 150 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nizatidine 150 MG Oral Capsule RxCUI 312025

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nizatidine 42319
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nizatidine Oral Capsule 373110
    • Nizatidine Oral Product 1159837
    • Nizatidine Pill 1159838
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Nizatidine 150 MG 316382

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nizatidine 150 MG SCDC · 316382
  • Nizatidine Oral Capsule SCDF · 373110
  • Nizatidine Oral Product SCDG · 1159837
  • Nizatidine Pill SCDG · 1159838

📦 FDA Products & Package NDCs

6 products · 16 package NDCs
16 package NDCs map to RxCUI 312025 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-3137-60 60 CAPSULE in 1 BOTTLE, PLASTIC (0591-3137-60) Nizatidine Actavis Pharma, Inc. 2002-07-09
00591-3138-30 30 CAPSULE in 1 BOTTLE, PLASTIC (0591-3138-30) Nizatidine Actavis Pharma, Inc. 2002-07-09
42806-0299-30 30 CAPSULE in 1 BOTTLE (42806-299-30) Nizatidine Epic Pharma, LLC 2024-10-25
42806-0299-60 60 CAPSULE in 1 BOTTLE (42806-299-60) Nizatidine Epic Pharma, LLC 2024-10-25
42806-0300-30 30 CAPSULE in 1 BOTTLE (42806-300-30) Nizatidine Epic Pharma, LLC 2024-10-25
42806-0300-60 60 CAPSULE in 1 BOTTLE (42806-300-60) Nizatidine Epic Pharma, LLC 2024-10-25
55111-0310-01 100 CAPSULE in 1 BOTTLE (55111-310-01) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0310-05 500 CAPSULE in 1 BOTTLE (55111-310-05) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0310-30 30 CAPSULE in 1 BOTTLE (55111-310-30) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0310-60 60 CAPSULE in 1 BOTTLE (55111-310-60) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0310-78 10 BLISTER PACK in 1 CARTON (55111-310-78) / 10 CAPSULE in... Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0311-01 100 CAPSULE in 1 BOTTLE (55111-311-01) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0311-05 500 CAPSULE in 1 BOTTLE (55111-311-05) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0311-30 30 CAPSULE in 1 BOTTLE (55111-311-30) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0311-60 60 CAPSULE in 1 BOTTLE (55111-311-60) Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
55111-0311-78 10 BLISTER PACK in 1 CARTON (55111-311-78) / 10 CAPSULE in... Nizatidine Dr Reddy's Laboratories Limited 2005-09-15
Observed labelers: Dr Reddy's Laboratories Limited (10) · Epic Pharma, LLC (4) · Actavis Pharma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.